S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
S&P 500   4,326.51
DOW   34,160.78
QQQ   341.10
NASDAQ:ANGO

AngioDynamics Insider Trades

$20.46
-0.82 (-3.85%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$20.03
$21.70
50-Day Range
$20.46
$29.16
52-Week Range
$18.29
$32.00
Volume
436,839 shs
Average Volume
524,030 shs
Market Capitalization
$792.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.89

AngioDynamics (NASDAQ:ANGO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.80%

Number Of
Insiders Buying
(Last 12 Months)
2

Amount Of
Insider Buying
(Last 12 Months)
$251.04 K

Number Of
Insiders Selling
(Last 12 Months)
3

Amount Of
Insider Selling
(Last 12 Months)
$808.33 K

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ANGO Insider Trade Alerts

Want to know when executives and insiders are buying or selling AngioDynamics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


AngioDynamics (NASDAQ ANGO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2022Stephen A TrowbridgeCFOBuy1,000$22.64$22,640.00  
1/11/2022James C ClemmerCEOBuy10,000$22.84$228,400.00  
10/20/2021Dave HelselSVPSell3,494$27.97$97,727.18  
10/15/2021Scott CenteaVPSell12,000$27.92$335,040.00  
10/5/2021Chad Thomas CampbellSVPSell10,748$27.15$291,808.20  
4/14/2021Dave HelselSVPSell3,500$23.93$83,755.0019,115  
1/20/2021Wesley JohnsonDirectorSell6,500$18.53$120,445.0077,911  
8/11/2020Stephen A TrowbridgeCFOBuy1,013$9.38$9,501.9460,273  
7/31/2020James C ClemmerCEOBuy40,000$8.26$330,400.00343,319  
10/25/2019James C ClemmerCEOBuy15,000$14.19$212,850.00260,418  
7/16/2019Kevin J GouldDirectorSell13,650$21.45$292,792.5061,774  
11/7/2018Michael GreinerCFOSell1,939$21.53$41,746.67  
7/24/2017Jan Stern ReedDirectorBuy316$16.00$5,056.00316  
7/21/2017James C ClemmerCEOBuy5,000$15.79$78,950.0086,683  
7/20/2017James C ClemmerCEOBuy20,000$15.64$312,800.0086,683  
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.0023,988  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.4820,910  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.0032,469  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.0027,005  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00  
(Data available from 1/1/2013 forward)












AngioDynamics (NASDAQ:ANGO) Insider Trade Frequently Asked Questions

Who is on AngioDynamics's Insider Roster?

The list of insiders at AngioDynamics includes Chad Thomas Campbell, Dave Helsel, James C Clemmer, Kevin J Gould, Scott Centea, Stephen A Trowbridge, and Wesley Johnson.Learn more on ANGO's insiders

What percentage of AngioDynamics stock is owned by insiders?

4.80% of AngioDynamics stock is owned by insiders. Learn more on ANGO's insider holdings

Which AngioDynamics insiders have been buying company stock?

The following insiders have purchased AngioDynamics stock in the last 24 months: James C Clemmer ($558,800.00), and Stephen A Trowbridge ($32,141.94).

How much insider buying is happening at AngioDynamics?

Insiders have purchased a total of 52,013 AngioDynamics shares in the last 24 months for a total of $590,941.94 bought.

Which AngioDynamics insiders have been selling company stock?

The following insiders have sold AngioDynamics stock in the last 24 months: Chad Thomas Campbell ($291,808.20), Dave Helsel ($181,482.18), Scott Centea ($335,040.00), and Wesley Johnson ($120,445.00).

How much insider selling is happening at AngioDynamics?

Insiders have sold a total of 36,242 AngioDynamics shares in the last 24 months for a total of $928,775.38 sold.

This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.